Texas 89th Legislature
Medicine & Prescription Drugs
6 high-impact bills require immediate attention. 11 bills have bipartisan support.
High-Impact Bills
6 bills require immediate attention
Relating to the medical use of low-THC cannabis under and the administration of the Texas Compassionate-Use Program; requiring registration.
Relating to prohibitions on the manufacture and provision of abortion-inducing drugs, including the jurisdiction of and effect of certain judgments by courts within and outside this state with respect to the manufacture and provision of those drugs, and to protections from certain counteractions under the laws of other states and jurisdictions; authorizing qui tam actions.
Relating to certain prohibited transactions and logistical support between a governmental entity and an abortion assistance entity or abortion provider for the procurement of an abortion or related services.
Relating to family support services provided under a Health and Human Services Commission program.
Relating to required reports of certain vaccine-related or drug-related adverse events.
Relating to the establishment of a consortium to conduct United States Food and Drug Administration's drug development clinical trials with ibogaine to secure the administration's approval of the medication's use for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy and to the administration of that treatment.
Medicine & Prescription Drugs Filing Activity
Compliance & Cost
Leading Authors
All Bills (17)
Relating to prohibitions on the manufacture and provision of abortion-inducing drugs, including the jurisdiction of and effect of certain judgments by courts within and outside this state with respect to the manufacture and provision of those drugs, and to protections from certain counteractions under the laws of other states and jurisdictions; authorizing qui tam actions.
Relating to prohibitions on the manufacture and provision of abortion-inducing drugs, including the jurisdiction of and effect of certain judgments by courts within and outside this state with respect to the manufacture and provision of those drugs, and to protections from certain counteractions under the laws of other states and jurisdictions; authorizing qui tam actions.
Relating to a pharmacist's authority to dispense ivermectin without a prescription.
Relating to a pharmacist's authority to dispense ivermectin without a prescription.
Relating to the medical use of low-THC cannabis under and the administration of the Texas Compassionate-Use Program; requiring registration.
Relating to the medical use of low-THC cannabis under and the administration of the Texas Compassionate-Use Program; requiring registration.
Relating to the possession and administration of epinephrine delivery systems by certain entities.
Relating to the possession and administration of epinephrine delivery systems by certain entities.
Relating to the availability and use of airway clearance devices at public school campuses and to contracts for medication for respiratory distress and training at public schools.
Relating to the availability and use of airway clearance devices at public school campuses and to contracts for medication for respiratory distress and training at public schools.
Relating to neglect of a child and the grounds for termination of the parent-child relationship and possession of a child by the Department of Family and Protective Services.
Relating to neglect of a child and the grounds for termination of the parent-child relationship and possession of a child by the Department of Family and Protective Services.
Relating to a report on governmental opioid antagonist programs to reverse and prevent opioid overdoses.
Relating to a report on governmental opioid antagonist programs to reverse and prevent opioid overdoses.
Relating to certain prohibited transactions and logistical support between a governmental entity and an abortion assistance entity or abortion provider for the procurement of an abortion or related services.
Relating to certain prohibited transactions and logistical support between a governmental entity and an abortion assistance entity or abortion provider for the procurement of an abortion or related services.
Relating to required reports of certain vaccine-related or drug-related adverse events.
Relating to required reports of certain vaccine-related or drug-related adverse events.
Relating to protection of certain disclosures and communications by pharmacists and pharmacies regarding prescription drug benefits.
Relating to protection of certain disclosures and communications by pharmacists and pharmacies regarding prescription drug benefits.
Relating to the administration of nonprescription medications to certain public and private school students.
Relating to the administration of nonprescription medications to certain public and private school students.
Relating to access to individualized investigational treatments for patients with life-threatening or severely debilitating illnesses.
Relating to access to individualized investigational treatments for patients with life-threatening or severely debilitating illnesses.
Relating to fire safety inspections at public and private schools.
Relating to fire safety inspections at public and private schools.
Relating to family support services provided under a Health and Human Services Commission program.
Relating to family support services provided under a Health and Human Services Commission program.
Relating to the use of an epinephrine delivery system by certain entities.
Relating to the use of an epinephrine delivery system by certain entities.
Relating to the establishment of a consortium to conduct United States Food and Drug Administration's drug development clinical trials with ibogaine to secure the administration's approval of the medication's use for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy and to the administration of that treatment.
Relating to the establishment of a consortium to conduct United States Food and Drug Administration's drug development clinical trials with ibogaine to secure the administration's approval of the medication's use for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy and to the administration of that treatment.
Relating to the establishment and powers and duties of the Texas Advisory Committee on Geopolitical Conflict.
Relating to the establishment and powers and duties of the Texas Advisory Committee on Geopolitical Conflict.
Frequently Asked Questions
- How many Texas laws on medicine & prescription drugs passed in 2025?
- The Texas 89th Legislature enacted 17 laws related to medicine & prescription drugs. These bills were authored by 16 different legislators and address various aspects of medicine & prescription drugs policy in Texas.
- Did medicine & prescription drugs bills originate in the Texas House or Senate?
- Medicine & Prescription Drugs legislation from the 89th Legislature includes 10 Senate bills and 7 House bills. Both chambers contributed significant legislation on this topic.
- Which Texas legislators authored the most medicine & prescription drugs bills?
- The leading authors of medicine & prescription drugs legislation include Sen. Lois Kolkhorst (R) with 2 bills, Sen. Carol Alvarado (D) with 1 bills, Sen. Charles Perry (R) with 1 bills. These lawmakers have demonstrated particular focus on medicine & prescription drugs issues during the 89th Legislature.
- How urgent are the compliance requirements for medicine & prescription drugs legislation?
- Among the 17 medicine & prescription drugs bills enacted, 5 have critical compliance urgency and 9 have moderate urgency. Businesses should prioritize reviewing high-urgency bills for immediate compliance planning.
- What subjects are related to medicine & prescription drugs in Texas law?
- Medicine & Prescription Drugs legislation frequently overlaps with Health & Human Services Commission, Health, Health Care Providers. Bills often address multiple related policy areas, so reviewing these connected subjects may provide additional context.
- Is there bipartisan support for medicine & prescription drugs legislation in Texas?
- Yes, 11 of the 17 medicine & prescription drugs bills (65%) have bipartisan sponsorship, with both Republican and Democrat sponsors. This indicates areas of cross-party agreement on medicine & prescription drugs policy.
- When do Texas medicine & prescription drugs laws from the 89th Legislature take effect?
- Most Texas legislation takes effect September 1, 2025, unless otherwise specified. Some medicine & prescription drugs bills may have immediate effective dates or delayed implementation schedules. Review individual bills for specific effective dates and compliance deadlines.
Need Strategic Guidance on This Legislation?
Need help with Government Relations, Lobbying, or compliance? JD Key Consulting has the expertise you're looking for.